BNR Burning Rock Biotech Ltd
$7.27 +5.21%
Healthcare · Services-Medical Laboratories
Burning Rock Biotech Ltd (BNR) is a healthcare company in the Services-Medical Laboratories industry. Shares last traded at $7.27, 82.5% below their 52-week high. Over the past year the stock is up 150.7%. Net profit margin is -10.3%, below the peer median of -8.0%. Revenue grew 9.2% year over year.
Market Cap
—
Shares Out
—
EPS (TTM)
—
P/E Ratio
—
P/S Ratio
—
P/B Ratio
—
Dividend / Share
—
Dividend Yield
—
52-Week High
$41.47
52-Week Low
$2.88
Volume
640
Avg Vol (3m)
719.429
Performance
1W
-17.67%
1M
-57.54%
3M
-60.55%
6M
-57.34%
YTD
-63.28%
1Y
+150.69%
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
RSI (14)
27.54
SMA (50)
$14.98
SMA (200)
$17.39
Price vs SMA50
-51.47%
Price vs SMA200
-58.19%
ATR (14)
$0.99
Financials
Revenue
$77M
Net Income
$-8M
Gross Margin
74.7%
Operating Margin
-10.2%
Net Margin
-10.3%
Return on Equity
-10.3%
Return on Assets
-6.7%
Current Ratio
2.99
Debt / Equity
0.53
Revenue Growth (YoY)
+9.2%
Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.
Services-Medical Laboratories peers
BNR vs 14 industry peers (Services-Medical Laboratories), by market cap.
1–14 of 14
| NTRA | Natera, Inc. | $33.1B | -159.23 | 14.37 | -9.0% | +2.17% |
| DGX | Quest Diagnostics | $21.6B | 21.76 | 1.96 | 9.0% | -1.44% |
| LH | Labcorp | $21.0B | 23.93 | 1.50 | 6.3% | -1.40% |
| GH | Guardant Health, Inc. | $17.5B | -41.98 | 17.80 | -42.4% | +2.06% |
| CAI | Caris Life Sciences, Inc. | $5.2B | — | — | — | +3.41% |
| BLLN | Billiontoone, Inc. | $4.8B | — | — | — | +5.38% |
| VCYT | Veracyte, Inc. | $4.3B | 64.47 | 8.28 | 12.8% | +4.50% |
| CELC | Celcuity Inc. | $4.3B | -24.15 | — | — | -0.45% |
| RDNT | Radnet, Inc. | $4.2B | -226.56 | 2.07 | -0.9% | +1.83% |
| GRAL | Grail, Inc. | $2.7B | — | — | — | +7.35% |
| FTRE | Fortrea Holdings Inc. | $1.4B | — | — | — | -0.20% |
| CDNA | Caredx, Inc. | $1.4B | -63.38 | 3.56 | -5.6% | +11.89% |
| PSNL | Personalis, Inc. | $1.1B | -13.55 | — | — | +8.29% |
| LMRI | Lumexa Imaging Holdings, Inc. | $907M | — | — | — | +7.76% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.